DANCAN — Dancann Pharma A/S Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Dancann Pharma A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	DAS	DAS	DAS	DAS	DAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	21.3	7.74	10.8	2.01	3.47
Net Total Accounts Receivable
Net Total Receivables	7.57	9.17	4.75	0.406	0.35
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	29.6	17.7	16.3	3.19	4.5
Net Property, Plant And Equipment	3.98	9.57	9.28	3.94	3.19
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	49.5	69	73.7	17.4	16.7
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.86	14.7	10.9	7.89	1.77
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	5.22	15.6	10.9	7.89	2.05
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	44.3	53.4	62.8	9.51	14.6
Total Liabilities & Shareholders' Equity	49.5	69	73.7	17.4	16.7
Total Common Shares Outstanding